SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001104659-23-123966
Filing Date
2023-12-06
Accepted
2023-12-06 16:10:49
Documents
18
Period of Report
2023-12-04
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tm2332233d1_8k.htm   iXBRL 8-K 36326
2 EXHIBIT 1.1 tm2332233d1_ex1-1.htm EX-1.1 268968
3 EXHIBIT 5.1 tm2332233d1_ex5-1.htm EX-5.1 8593
4 EXHIBIT 99.1 tm2332233d1_ex99-1.htm EX-99.1 11590
5 EXHIBIT 99.2 tm2332233d1_ex99-2.htm EX-99.2 10893
9 GRAPHIC tm2332233d1_ex99-1img01.jpg GRAPHIC 7341
10 GRAPHIC tm2332233d1_ex99-2img01.jpg GRAPHIC 7341
  Complete submission text file 0001104659-23-123966.txt   605066

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA swtx-20231204.xsd EX-101.SCH 3030
7 XBRL TAXONOMY EXTENSION LABEL LINKBASE swtx-20231204_lab.xml EX-101.LAB 34240
8 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE swtx-20231204_pre.xml EX-101.PRE 22369
12 EXTRACTED XBRL INSTANCE DOCUMENT tm2332233d1_8k_htm.xml XML 3223
Mailing Address 100 WASHINGTON BOULEVARD STAMFORD CT 06902
Business Address 100 WASHINGTON BOULEVARD STAMFORD CT 06902 203-883-9490
SpringWorks Therapeutics, Inc. (Filer) CIK: 0001773427 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39044 | Film No.: 231469703
SIC: 2836 Biological Products, (No Diagnostic Substances)
Office of Life Sciences